SAUDI MEDICAL JOURNAL, vol.34, no.5, pp.497-502, 2013 (SCI-Expanded)
Objectives: To evaluate the effects of 25-hydroxycholecalciferol (25-[OH] D) on bone mineral metabolism and inflammation parameters in hemodialysis patients.